BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34323067)

  • 1. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD.
    Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z
    J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
    Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
    Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
    Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
    J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.
    Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice.
    Yenilmez B; Kelly M; Zhang GF; Wetoska N; Ilkayeva OR; Min K; Rowland L; DiMarzio C; He W; Raymond N; Lifshitz L; Pan M; Han X; Xie J; Friedline RH; Kim JK; Gao G; Herman MA; Newgard CB; Czech MP
    J Biol Chem; 2022 Oct; 298(10):102401. PubMed ID: 35988648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.
    Li K; Zhang K; Wang H; Wu Y; Chen N; Chen J; Qiu C; Cai P; Li M; Liang X; Su D
    Metabolism; 2021 Jan; 114():154349. PubMed ID: 32888949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells.
    Li Z; Li D; Choi EY; Lapidus R; Zhang L; Huang SM; Shapiro P; Wang H
    J Biol Chem; 2017 Aug; 292(33):13890-13901. PubMed ID: 28655760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.
    Zhao S; Jang C; Liu J; Uehara K; Gilbert M; Izzo L; Zeng X; Trefely S; Fernandez S; Carrer A; Miller KD; Schug ZT; Snyder NW; Gade TP; Titchenell PM; Rabinowitz JD; Wellen KE
    Nature; 2020 Mar; 579(7800):586-591. PubMed ID: 32214246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
    Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
    Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse.
    Fernandez-Fuente G; Overmyer KA; Lawton AJ; Kasza I; Shapiro SL; Gallego-Muñoz P; Coon JJ; Denu JM; Alexander CM; Puglielli L
    Commun Biol; 2023 Sep; 6(1):926. PubMed ID: 37689798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
    Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
    FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
    Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
    Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
    Granchi C
    Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes.
    Neuschäfer-Rube F; Schraplau A; Schewe B; Lieske S; Krützfeldt JM; Ringel S; Henkel J; Birkenfeld AL; Püschel GP
    Toxicology; 2015 Nov; 337():1-9. PubMed ID: 26303333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery.
    Zhang L; Hu W; Qiu Z; Li Z; Bian J
    J Med Chem; 2023 Jul; 66(14):9229-9250. PubMed ID: 37428122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N; Royaux I; Swinnen JV; Smans K
    Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth.
    Dirckx N; Zhang Q; Chu EY; Tower RJ; Li Z; Guo S; Yuan S; Khare PA; Zhang C; Verardo A; Alejandro LO; Park A; Faugere MC; Helfand SL; Somerman MJ; Riddle RC; de Cabo R; Le A; Schmidt-Rohr K; Clemens TL
    Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2212178119. PubMed ID: 36322718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.